« Modern obesity trends pushing up diabetes rate | Main | Increasing incidence of diabetes in the young »
Spray for diabetes approved in India
By Diabetes Affected | November 20, 2008
For people with diabetes, regular and periodic injections of insulin are the way to go. These enable moving the insulin directly to the blood-stream, and is most effective. However, frequent injections is not for everyone, since there is a lot of discomfort involved. Injecting yourself on a regular basis means that you need to find new injection points, and some people complain that it makes them feel like a pin-cushion. A frequent request is for a non-injectible method, either through a pill or through a spray, with a lot of research going in these directions - so one can be sure that there will be a lot more developments in these directions soon.
Here is a spray that has been okayed in India (a huge market for diabetics related medicines), but not yet in the United States:
Diabetes patients on insulin, suffering from acute injection phobia, have an alternative with the launch of Oral-Recosulin, a recombinant DNA human insulin buccal spray. The spray, which is on phase-3 trial and yet to be launched in the US, has been approved for marketing in India
For the treatment of both Type-1 and Type-2 diabetes, Oral-Recosulin can be used. This buccal insulin spray is developed by Shreya Life Science Pvt Ltd’s US collaborator Generex Biotechnology. Buccal spray delivers insulin through buccal mucosa, directly to the vascular system without entering the lungs.
Diabetes is a disease that is long lasting, currently non-curable, and hence attempts to make treatment pain free have a double benefit of being very attractive from a commercial sense as well as making the treatment more bearable.
Topics: Injection, Pain, Treatment |